2BB score and signals
Acrivon Therapeutics, Inc.’s current 2BB score is 21 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 35 | Weakening |
| Financial strength | 20 | Weak |
| Quality | 80 | Very Strong |
| Risk | 42 | Moderate |
Company facts
| Headquarters | Watertown, Massachusetts, United States |
| Founded | 2018 |
| Employees | 75 |
| 52-week range | $1.26 – $3.55 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-11 | — | -0.4792 | — | $0.00 |
| 2026-08-19 | — | -0.51 | — | $0.00 |
| 2026-05-13 | -0.49 | -0.5359 | $0.00 | $282,203.00 |
| 2026-03-19 | -0.52 | -0.4756 | $0.00 | $169,024.00 |
Related companies
2BBBullish & Bearish